Login
Home
Charts
Search
Watchlist
Products

Hindustan Organic Chemicals Ltd

HOCL·BSE
46.07+6.52%Thu, 24 Sept '26

Hindustan Organic Chemicals Ltd

HOCL
BSE
46.07
+6.52%
|Thu, 24 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
310Cr
Close
Close Price
46.10
Industry
Industry
Chemicals - Others
PE
Price To Earnings
PS
Price To Sales
0.61
Revenue
Revenue
506Cr
Rev Gr TTM
Revenue Growth TTM
-21.01%
PAT Gr TTM
PAT Growth TTM
-100.60%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1891871835917516513716412614713696
Growth YoY
Revenue Growth YoY%
35.47.5-5.7-59.2-7.4-11.6-25.3176.1-27.7-10.8-0.2-41.4
Expenses
ExpensesCr
1771901838317519117317714315112091
Operating Profit
Operating ProfitCr
11-3-1-240-26-37-13-17-4175
OPM
OPM%
6.1-1.7-0.3-39.60.0-15.7-26.9-8.2-13.6-2.512.25.0
Other Income
Other IncomeCr
53645-34551125544
Interest Expense
Interest ExpenseCr
171817161818-1055555
Depreciation
DepreciationCr
000000000110
PBT
PBTCr
-2-18-12-36-14-79523-7-18-4154
Tax
TaxCr
0000003000-10
PAT
PATCr
-2-18-12-35-14-79520-6-18-4164
Growth YoY
PAT Growth YoY%
92.2-29.1-108.2-53.2-718.8-348.04,528.782.4-34.595.1-97.0161.7
NPM
NPM%
-0.9-9.5-6.4-59.5-7.7-47.9380.6-3.8-14.4-2.611.54.0
EPS
EPS
-0.3-2.6-1.8-5.32.1-11.877.4-0.9-2.7-0.62.30.6
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1891871835917516513716412614713696
Growth YoY
Revenue Growth YoY%
35.47.5-5.7-59.2-7.4-11.6-25.3176.1-27.7-10.8-0.2-41.4
Expenses
ExpensesCr
1771901838317519117317714315112091
Operating Profit
Operating ProfitCr
11-3-1-240-26-37-13-17-4175
OPM
OPM%
6.1-1.7-0.3-39.60.0-15.7-26.9-8.2-13.6-2.512.25.0
Other Income
Other IncomeCr
53645-34551125544
Interest Expense
Interest ExpenseCr
171817161818-1055555
Depreciation
DepreciationCr
000000000110
PBT
PBTCr
-2-18-12-36-14-79523-7-18-4154
Tax
TaxCr
0000003000-10
PAT
PATCr
-2-18-12-35-14-79520-6-18-4164
Growth YoY
PAT Growth YoY%
92.2-29.1-108.2-53.2-718.8-348.04,528.782.4-34.595.1-97.0161.7
NPM
NPM%
-0.9-9.5-6.4-59.5-7.7-47.9380.6-3.8-14.4-2.611.54.0
EPS
EPS
-0.3-2.6-1.8-5.32.1-11.877.4-0.9-2.7-0.62.30.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
144177279511331415434631704536574506
Growth
Revenue Growth%
-19.422.757.683.0-35.125.34.445.611.5-23.97.1-21.0
Expenses
ExpensesCr
266336449484390388433625705622591505
Operating Profit
Operating ProfitCr
-121-159-17027-592716-1-86-181
OPM
OPM%
-84.1-89.8-60.85.3-17.86.40.21.0-0.1-16.1-3.10.1
Other Income
Other IncomeCr
566611721213411175262618
Interest Expense
Interest ExpenseCr
699878685854666770432020
Depreciation
DepreciationCr
1096333111222
PBT
PBTCr
-185-259-18773-98-8-32-51-55395-14-4
Tax
TaxCr
0000000003-1-1
PAT
PATCr
-185-259-18773-98-8-32-51-55392-13-3
Growth
PAT Growth%
14.8-40.227.9139.2-233.691.5-290.0-57.4-8.8807.8-103.3-100.6
NPM
NPM%
-128.1-146.4-67.014.3-29.5-2.0-7.5-8.1-7.973.1-2.3-0.5
EPS
EPS
-27.5-38.6-27.810.9-14.6-1.2-4.8-8.2-8.158.3-1.9-0.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
144177279511331415434631704536574506
Growth
Revenue Growth%
-19.422.757.683.0-35.125.34.445.611.5-23.97.1-21.0
Expenses
ExpensesCr
266336449484390388433625705622591505
Operating Profit
Operating ProfitCr
-121-159-17027-592716-1-86-181
OPM
OPM%
-84.1-89.8-60.85.3-17.86.40.21.0-0.1-16.1-3.10.1
Other Income
Other IncomeCr
566611721213411175262618
Interest Expense
Interest ExpenseCr
699878685854666770432020
Depreciation
DepreciationCr
1096333111222
PBT
PBTCr
-185-259-18773-98-8-32-51-55395-14-4
Tax
TaxCr
0000000003-1-1
PAT
PATCr
-185-259-18773-98-8-32-51-55392-13-3
Growth
PAT Growth%
14.8-40.227.9139.2-233.691.5-290.0-57.4-8.8807.8-103.3-100.6
NPM
NPM%
-128.1-146.4-67.014.3-29.5-2.0-7.5-8.1-7.973.1-2.3-0.5
EPS
EPS
-27.5-38.6-27.810.9-14.6-1.2-4.8-8.2-8.158.3-1.9-0.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
6767676767676767676767
Reserves
ReservesCr
-1,12152-3344-50-36-72-118-119272258
Current Liabilities
Current LiabilitiesCr
6121,4371,1479821,0231,1721,3221,3841,472362363
Non Current Liabilities
Non Current LiabilitiesCr
398275494477354269192177188187186
Total Liabilities
Total LiabilitiesCr
2271,8171,6591,5511,3741,4401,4751,4741,5721,5591,542
Current Assets
Current AssetsCr
951201,5011,3731,1921,3001,3151,3021,3401,3221,305
Non Current Assets
Non Current AssetsCr
1311,697158178182141160172233237237
Total Assets
Total AssetsCr
2271,8171,6591,5511,3741,4401,4751,4741,5721,5591,542
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
6767676767676767676767
Reserves
ReservesCr
-1,12152-3344-50-36-72-118-119272258
Current Liabilities
Current LiabilitiesCr
6121,4371,1479821,0231,1721,3221,3841,472362363
Non Current Liabilities
Non Current LiabilitiesCr
398275494477354269192177188187186
Total Liabilities
Total LiabilitiesCr
2271,8171,6591,5511,3741,4401,4751,4741,5721,5591,542
Current Assets
Current AssetsCr
951201,5011,3731,1921,3001,3151,3021,3401,3221,305
Non Current Assets
Non Current AssetsCr
1311,697158178182141160172233237237
Total Assets
Total AssetsCr
2271,8171,6591,5511,3741,4401,4751,4741,5721,5591,542

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4659-451-160-81-5010-13-66631-70
Investing Cash Flow
Investing Cash FlowCr
-603431121648117561012
Financing Cash Flow
Financing Cash FlowCr
-48-591793-9052-32-106-64258
Net Cash Flow
Net Cash FlowCr
-8072-45-89-11-16-4-10
Free Cash Flow
Free Cash FlowCr
4059-109-5375-4910-14-67624-72
CFO To PAT
CFO To PAT%
-24.9-22.9240.9-219.183.2599.7-30.725.1118.8161.3546.6
CFO To EBITDA
CFO To EBITDA%
-38.0-37.4265.6-588.9138.2-185.71,178.8-202.56,591.8-733.1400.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4659-451-160-81-5010-13-66631-70
Investing Cash Flow
Investing Cash FlowCr
-603431121648117561012
Financing Cash Flow
Financing Cash FlowCr
-48-591793-9052-32-106-64258
Net Cash Flow
Net Cash FlowCr
-8072-45-89-11-16-4-10
Free Cash Flow
Free Cash FlowCr
4059-109-5375-4910-14-67624-72
CFO To PAT
CFO To PAT%
-24.9-22.9240.9-219.183.2599.7-30.725.1118.8161.3546.6
CFO To EBITDA
CFO To EBITDA%
-38.0-37.4265.6-588.9138.2-185.71,178.8-202.56,591.8-733.1400.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11216515615467266188150264286148310
Price To Earnings
Price To Earnings
2.1104.30.7
Price To Sales
Price To Sales
0.80.90.60.30.20.60.40.20.40.50.30.6
Price To Book
Price To Book
-0.11.44.51.43.98.4-39.4-3.0-5.10.80.50.9
EV To EBITDA
EV To EBITDA
-3.7-3.2-3.422.2-6.720.71,003.3121.6-846.9-2.8-10.4429.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.628.924.125.211.629.716.49.88.2-4.17.27.2
OPM
OPM%
-84.1-89.8-60.85.3-17.86.40.21.0-0.1-16.1-3.10.1
NPM
NPM%
-128.1-146.4-67.014.3-29.5-2.0-7.5-8.1-7.973.1-2.3-0.5
ROCE
ROCE%
16.2-35.1-19.622.4-8.99.74.12.11.880.21.11.1
ROE
ROE%
17.6-217.7-544.266.1-563.3-26.3676.8101.2107.5115.3-4.0-4.0
ROA
ROA%
-81.6-14.3-11.34.7-7.1-0.6-2.2-3.5-3.525.1-0.8-0.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11216515615467266188150264286148310
Price To Earnings
Price To Earnings
2.1104.30.7
Price To Sales
Price To Sales
0.80.90.60.30.20.60.40.20.40.50.30.6
Price To Book
Price To Book
-0.11.44.51.43.98.4-39.4-3.0-5.10.80.50.9
EV To EBITDA
EV To EBITDA
-3.7-3.2-3.422.2-6.720.71,003.3121.6-846.9-2.8-10.4429.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.628.924.125.211.629.716.49.88.2-4.17.27.2
OPM
OPM%
-84.1-89.8-60.85.3-17.86.40.21.0-0.1-16.1-3.10.1
NPM
NPM%
-128.1-146.4-67.014.3-29.5-2.0-7.5-8.1-7.973.1-2.3-0.5
ROCE
ROCE%
16.2-35.1-19.622.4-8.99.74.12.11.880.21.11.1
ROE
ROE%
17.6-217.7-544.266.1-563.3-26.3676.8101.2107.5115.3-4.0-4.0
ROA
ROA%
-81.6-14.3-11.34.7-7.1-0.6-2.2-3.5-3.525.1-0.8-0.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
- Hindustan Organic Chemicals Ltd is a government-owned manufacturer that has been making the same three bulk industrial chemicals - phenol, acetone and hydrogen peroxide - for over five decades, and is now fighting for survival. The company was incorporated in 1960 as a Central Public Sector Undertaking under the Ministry of Chemicals & Fertilizers, and the President of India still holds a 58.78% stake. Everything HOCL does today is shaped by a government-approved restructuring plan: it has shut its loss-making second unit, is selling legacy land to pay down debt, and recently had Parliament waive over Rs. 1,350 crores in government dues - all while trying to keep its ageing Kochi plant running against larger, more modern competitors. # Business segments A single chemical manufacturing engine at Kochi - producing phenol, acetone and hydrogen peroxide from petroleum feedstocks - that is being kept alive through restructuring while the company sells land and winds down a failed subsidiary. ## 1. Kochi Phenol Complex: the sole operating engine, under siege **A 40,000-tonne phenol plant and a hydrogen peroxide unit run on raw materials piped in from BPCL, but the complex is too small and too old to compete without government protection.** - **Three products from two plants** - the Phenol plant makes phenol (40,000 MT per year capacity) and its co-product acetone (24,640 MT per year), while a separate Hydrogen Peroxide plant adds another 10,450 MT per year, for a total installed capacity of 75,090 MT per year. These chemicals are the building blocks for dyes, agrochemicals and pharmaceuticals. - **Fed by a single pipeline** - LPG, benzene, furnace oil and hydrogen, supplied by BPCL through a direct pipeline connection, make up 95% of everything HOCL buys by value. That pipeline is both a lifeline and a vulnerability: in March 2026, BPCL cut LPG supply under a government directive, forcing a temporary plant shutdown. - **Outgunned by private rivals** - private-sector competitors have set up phenol capacities of up to 200,000 MT, five times HOCL's 40,000 MT, and without anti-dumping duties the Kochi unit cannot compete against imports. The company itself lists outdated technology, high fixed costs that its small scale cannot absorb, and an inability to diversify as structural weaknesses. - **Squeezed on every side** - the plant faces volatile international prices for its products, fluctuating input costs, high utility and manpower expenses, and depreciated equipment that demands heavy maintenance. Working capital to keep operations running is a persistent worry. - **Small wins at the margins** - the company switched its boilers and heaters from furnace oil to regasified LNG, cutting both cost and air pollution, and it buys power through open-access trading to save on electricity. An in-house process tweak reduced raw-material consumption enough to save Rs. 4,186 lakhs in FY24. A tar-cracking unit commissioned recently is expected to add roughly Rs. 5 crores a year, and the company has begun making acetophenone as a new product. # Group structure and partners **HOCL is a single-chemicals-segment government company with one subsidiary in terminal closure and a critical raw-material dependency on BPCL.** - **Hindustan Fluorocarbons Ltd - a subsidiary being wound down** - HOCL owns 56.43% of HFL, but the Cabinet directed its closure in 2020 after a failed disinvestment attempt drew no bidders. HFL had zero turnover in FY25, its plant and machinery have already been sold through e-auction, and it is now in the process of delisting from the Bombay Stock Exchange. - **Land sales as a financial lifeline** - the company is selling unencumbered land at Rasayani and Panvel, with 33.35 acres sold to BPCL itself during 2024 for Rs. 46.69 crores, as part of the government-approved plan to reduce liabilities.

Documents — Hindustan Organic Chemicals Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/u1u00l3j4sj9kplizmjoh7aj.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/it5rwasol8gcxz88dopvb4uh.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/4u7xvgfbrw31v3hgzub12z8d.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/m7fmkbmqt7nhi68r27yug5h0.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/xu36i780hfd0ob6hn2abt13l.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/3ntwyzbg7sqtvgdw9xtkuxv2.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/2csk9y1g4v89twp5mmzppnjp.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/q5ixyu2guclkfsfdyeik1m34.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/hq2ff23ry9gkhrlkaafgvkki.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/nxi9b68tz92pxa650s6jev76.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/mhwqqzehsxorq5hyrzrettac.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/42jkonei52knvs2csqez0zsz.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/cjpmzsutqqug32t7lhxg95me.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/uu7p0x7aouaeewexv57ccrlf.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/sbn5y0g7fnz3cj914wwajdrc.pdf